Document is current
Any future updates will be listed below
-
Authors
Abud, Edsel M.
White, Andrew A.
-
Funding
Funding for this research was provided by:
NIH/NCATS (KL2TR002552)
- License Information
-
More Information
Article History
Accepted: 3 January 2024
First Online: 13 January 2024
Compliance with Ethical Standards
:
: E.M.A is co-inventor of patent WO/2018/160496 (microglia differentiation and use) and serves as advisory board member and consulting agreements with StemPharm Inc. and Neucyte Inc. and advisory participant for Amgen and AstraZeneca. AAW is on the speaker’s bureau for Astrazeneca/Amgen, GSK, Optinose, Regeneron/Sanofi, and Blueprint Pharmaceuticals. AAW is an advisory board member for Cogent Pharmaceuticals, Blueprint Pharmaceuticals, Regeneron/Sanofi, AstraZeneca and GSK. AAW has research support from AstraZeneca and Regeneron.
: This article does not contain any studies with human or animal subjects peformed by any of the authors.
